Главная › Немелкоклеточный рак легкого › Миссури › St. Louis
Клинические исследования Немелкоклеточный рак легкого в городе St. Louis, MO
73 исследований по теме Немелкоклеточный рак легкого ищут участников в центрах в городе St. Louis и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Набор участниковФаза 3
- Cancer Care Center of O'Fallon, O'Fallon · 16 миль отсюда
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 миль отсюда
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набор участниковФаза 3
- Washington University School of Medicine, St Louis
- Veteran's Affairs Medical Center - Saint Louis, St Louis
- Mercy Hospital South, St Louis
- и еще 7
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Washington University Medicine, St Louis
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Набор участниковФаза 2
- Missouri Baptist Medical Center, St Louis
- Cancer Care Center of O'Fallon, O'Fallon · 16 миль отсюда
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 миль отсюда
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набор участниковФаза 1
- Washington University School of Medicine in St. Louis, St Louis
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Набор участниковФаза 3
- Washington University School of Medicine ( Site 3279), St Louis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 2
- Washington University, School of Medicine, St Louis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Набор участниковФаза 3
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Набор участниковФаза 1
- Washington University School of Medicine, St Louis
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Набор участниковФаза 3
- Washington University Center for Advanced Medicine, St Louis
A Study of PHN-012 in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- PHN-012-001 Site, St Louis
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Набор участниковФаза 3
- Washington University School of Medicine - Siteman Cancer Center, St Louis
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Набор участниковФаза 2
- Washington University School Of Medicine, St Louis
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Набор участниковФаза 3
- Mercy South - David M Sindelar Cancer Center ( Site 0098), St Louis
- Mercy Research - David C. Pratt Cancer Center ( Site 0006), St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Набор участниковНаблюдательное исследование
- Washington University, St Louis
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Набор участниковФаза 3
- Research Site, Bridgeton · 15 миль отсюда
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Washington University in St Louis, St Louis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Washington University School Of Medicine, St Louis
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Набор участниковФаза 1
- Research Site, St Louis
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Washington University School of Medicine, St Louis
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Набор участниковФаза 2
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- и еще 4
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Missouri Baptist Medical Center, St Louis
Pan-tumor MRD Study
Набор участниковНаблюдательное исследование
- Cancer Care Specialists of Illinois (CCSI), O'Fallon · 16 миль отсюда
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Набор участниковФаза 1/2
- Local Institution - 0140, St Louis
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 1
- Washington University School of Medicine, St Louis
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Набор участниковФаза 3
- Local Institution - 0685, Fenton · 15 миль отсюда
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Набор участниковФаза 2/3
- SSM Health Cancer Care - St. Clare, Fenton · 15 миль отсюда
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Набор участниковФаза 2/3
- Washington University School of Medicine, St Louis
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
Набор участниковФаза 1
- Washington University School of Medicine, St Louis
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 3
- Research Site, Bridgeton · 15 миль отсюда
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Набор участниковФаза 1/2
- Washington University, St Louis
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
Набор участниковФаза 2
- Washington University School of Medicine, St Louis
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Набор участниковФаза 3
- Clinical Study Site, St Louis
- Clinical Study Site, St Louis
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набор участниковФаза 1/2
- Washington University, St Louis
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2/3
- Washington University-School of Medicine /ID# 262759, St Louis
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Набор участниковФаза 2
- Siteman Cancer Center - Washington University Medical Campus, St Louis
A Study of KK2269 in Adult Participants With Solid Tumors
Набор участниковФаза 1
- Washington University, St Louis
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Набор участниковФаза 1
- Washington University School of Medicine, St Louis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Набор участниковФаза 3
- Missouri Baptist Medical Center, St Louis
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Набор участниковФаза 3
- Research Site, Bridgeton · 15 миль отсюда
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Набор участниковФаза 3
- Research Site, St Louis
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Набор участниковФаза 1
- Washington University, Siteman Cancer Center, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- Research Site, St Louis
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набор участниковФаза 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и еще 4
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
Набор участниковФаза 2
- Washington University School of Medicine-Sitemen Cancer Center, St Louis
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Siteman Cancer Center - Washington University, St Louis
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
Набор участниковФаза 3
- Barnes-Jewish Hospital - Siteman Cancer Center (Washington University - St. Louis), St Louis
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Набор участниковФаза 3
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- и еще 4
First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Набор участниковФаза 1/2
- Washington University School of Medicine, St Louis
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Набор участниковНаблюдательное исследование
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Набор участниковФаза 3
- University of Kansas Cancer Center - Overland Park, Overland · 10 миль отсюда
A Study of LY4175408 in Participants With Advanced Cancer
Набор участниковФаза 1
- Washington University, St Louis
Study of XB010 in Subjects With Solid Tumors
Набор участниковФаза 1
- Siteman Cancer Center, St Louis
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- Research Site, St Louis
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Набор участниковФаза 1/2
- Washington University, St Louis
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набор участниковФаза 1
- Research Site, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Набор участниковФаза 1
- Washington University School of Medicine, St Louis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набор участниковФаза 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- и еще 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Набор участниковФаза 1/2
- Washington University Infusion Center Pharmacy, St Louis
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Набор участниковФаза 1
- Washington University School of Medicine, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Набор участниковФаза 2
- Siteman Cancer Center, Washington University, St Louis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- BJC Outpatient Center at Sunset Hills, Sunset Hills · 13 миль отсюда
- и еще 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2/3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и еще 7
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набор участниковФаза 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- и еще 4
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набор участниковФаза 1/2
- Washington University School of Medicine, St Louis
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набор участниковНаблюдательное исследование
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- Mercy Hospital Saint Louis, St Louis
- и еще 4
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- Washington University, St Louis
GEMINI-NSCLC: NSCLC Biomarker Study
Набор участниковНаблюдательное исследование
- Mercy Clinic Oncology and Hematology - Sindelar Cancer Center, St Louis
- Mercy Clinic Oncology and Hematology - David C. Pratt Cancer Center, St Louis
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Набор участниковФаза 1
- Washington University Medical Campus, St Louis
Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer
Набор участников
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набор участниковНаблюдательное исследование
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Набор участниковФаза 1/2
- Washington University, St Louis
Исследования Немелкоклеточный рак легкого в других городах
- Houston, TX145 исследований
- New York City, NY121 исследование
- Arlington, VA104 исследований
- Nashville, TN97 исследований
- Boston, MA90 исследований
- Los Angeles, CA87 исследований
- Chicago, IL61 исследование
- Baltimore, MD60 исследований
- San Antonio, TX59 исследований
- Columbus, OH57 исследований
- Washington, DC55 исследований
- Seattle, WA53 исследований
Другие исследования в городе St. Louis
- Рак молочной железы64 исследований
- Метастатический рак54 исследований
- Колоректальный рак50 исследований
- Рак (все виды)46 исследований
- Рак простаты46 исследований
- Рак легких39 исследований
- Рак яичников38 исследований
- Рак поджелудочной железы33 исследований
- Рак эндометрия29 исследований
- Плоскоклеточный рак головы и шеи28 исследований
- Сердечная недостаточность26 исследований
- Ожирение25 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.